These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
752 related articles for article (PubMed ID: 32653463)
1. Vaccines for COVID-19: The current state of play. Koirala A; Joo YJ; Khatami A; Chiu C; Britton PN Paediatr Respir Rev; 2020 Sep; 35():43-49. PubMed ID: 32653463 [TBL] [Abstract][Full Text] [Related]
2. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand? Al-Kassmy J; Pedersen J; Kobinger G Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685 [TBL] [Abstract][Full Text] [Related]
3. A systematic review of SARS-CoV-2 vaccine candidates. Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445 [TBL] [Abstract][Full Text] [Related]
4. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses. Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2: A New Song Recalls an Old Melody. Subbarao K Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706 [TBL] [Abstract][Full Text] [Related]
6. Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses. Gupta T; Gupta SK Int Immunopharmacol; 2020 Sep; 86():106717. PubMed ID: 32585611 [TBL] [Abstract][Full Text] [Related]
7. [Strategies for vaccine development of COVID-19]. Yang L; Tian D; Liu W Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines. De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679 [TBL] [Abstract][Full Text] [Related]
9. Developing a low-cost and accessible COVID-19 vaccine for global health. Hotez PJ; Bottazzi ME PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008548. PubMed ID: 32726304 [No Abstract] [Full Text] [Related]
10. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies. Frederiksen LSF; Zhang Y; Foged C; Thakur A Front Immunol; 2020; 11():1817. PubMed ID: 32793245 [TBL] [Abstract][Full Text] [Related]
11. Lessons for COVID-19 Immunity from Other Coronavirus Infections. Sariol A; Perlman S Immunity; 2020 Aug; 53(2):248-263. PubMed ID: 32717182 [TBL] [Abstract][Full Text] [Related]
12. Developing Covid-19 Vaccines at Pandemic Speed. Lurie N; Saville M; Hatchett R; Halton J N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757 [No Abstract] [Full Text] [Related]
13. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Dai L; Zheng T; Xu K; Han Y; Xu L; Huang E; An Y; Cheng Y; Li S; Liu M; Yang M; Li Y; Cheng H; Yuan Y; Zhang W; Ke C; Wong G; Qi J; Qin C; Yan J; Gao GF Cell; 2020 Aug; 182(3):722-733.e11. PubMed ID: 32645327 [TBL] [Abstract][Full Text] [Related]
14. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Usmani SS; Raghava GPS Front Immunol; 2020; 11():561851. PubMed ID: 33133071 [No Abstract] [Full Text] [Related]
16. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines. Shih HI; Wu CJ; Tu YF; Chi CY Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623 [TBL] [Abstract][Full Text] [Related]
17. Are Genetic Vaccines the Right Weapon against COVID-19? Conforti A; Marra E; Roscilli G; Palombo F; Ciliberto G; Aurisicchio L Mol Ther; 2020 Jul; 28(7):1555-1556. PubMed ID: 32553431 [No Abstract] [Full Text] [Related]
18. A vaccine is not too far for COVID-19. Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830 [No Abstract] [Full Text] [Related]
19. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409 [TBL] [Abstract][Full Text] [Related]